» Articles » PMID: 24792327

Downregulation of Pink1 Influences Mitochondrial Fusion-fission Machinery and Sensitizes to Neurotoxins in Dopaminergic Cells

Overview
Journal Neurotoxicology
Date 2014 May 6
PMID 24792327
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

It is now well established that mitochondria are organelles that, far from being static, are subject to a constant process of change. This process, which has been called mitochondrial dynamics, includes processes of both fusion and fission. Loss of Pink1 (PTEN-induced putative kinase 1) function is associated with early onset recessive Parkinson's disease and it has been proposed that mitochondrial dynamics might be affected by loss of the mitochondrial kinase. Here, we report the effects of silencing Pink1 on mitochondrial fusion and fission events in dopaminergic neuron cell lines. Cells lacking Pink1 were more sensitive to cell death induced by C2-Ceramide, which inhibits proliferation and induces apoptosis. In the same cell lines, mitochondrial morphology was fragmented and this was enhanced by application of forskolin, which stimulates the cAMP pathway that phosphorylates Drp1 and thereby inactivates it. Cells lacking Pink1 had lower Drp1 and Mfn2 expression. Based on these data, we propose that Pink1 may exert a neuroprotective role in part by limiting mitochondrial fission.

Citing Articles

Formoterol Acting via β2-Adrenoreceptor Restores Mitochondrial Dysfunction Caused by Parkinson's Disease-Related UQCRC1 Mutation and Improves Mitochondrial Homeostasis Including Dynamic and Transport.

Chang J, Chang H, Chao Y, Huang C, Lin C, Wu Z Biology (Basel). 2024; 13(4).

PMID: 38666843 PMC: 11048601. DOI: 10.3390/biology13040231.


The role of mitochondrial dynamics in disease.

Wang Y, Dai X, Li H, Jiang H, Zhou J, Zhang S MedComm (2020). 2023; 4(6):e462.

PMID: 38156294 PMC: 10753647. DOI: 10.1002/mco2.462.


Therapeutic Effects of Mesenchymal Stromal Cells Require Mitochondrial Transfer and Quality Control.

Mukkala A, Jerkic M, Khan Z, Szaszi K, Kapus A, Rotstein O Int J Mol Sci. 2023; 24(21).

PMID: 37958771 PMC: 10647450. DOI: 10.3390/ijms242115788.


P2X7 Receptor and Purinergic Signaling: Orchestrating Mitochondrial Dysfunction in Neurodegenerative Diseases.

Zelentsova A, Deykin A, Soldatov V, Ulezko A, Borisova A, Belyaeva V eNeuro. 2022; 9(6).

PMID: 36376084 PMC: 9665882. DOI: 10.1523/ENEURO.0092-22.2022.


Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases.

Bhatti G, Gupta A, Pahwa P, Khullar N, Singh S, Navik U Biomed J. 2022; 45(5):733-748.

PMID: 35568318 PMC: 9661512. DOI: 10.1016/j.bj.2022.05.002.


References
1.
Santos D, Cardoso S . Mitochondrial dynamics and neuronal fate in Parkinson's disease. Mitochondrion. 2012; 12(4):428-37. DOI: 10.1016/j.mito.2012.05.002. View

2.
Deng H, Dodson M, Huang H, Guo M . The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci U S A. 2008; 105(38):14503-8. PMC: 2567186. DOI: 10.1073/pnas.0803998105. View

3.
Mitra K . Mitochondrial fission-fusion as an emerging key regulator of cell proliferation and differentiation. Bioessays. 2013; 35(11):955-64. DOI: 10.1002/bies.201300011. View

4.
Santel A, Frank S . Shaping mitochondria: The complex posttranslational regulation of the mitochondrial fission protein DRP1. IUBMB Life. 2008; 60(7):448-55. DOI: 10.1002/iub.71. View

5.
Mitra K, Lippincott-Schwartz J . Analysis of mitochondrial dynamics and functions using imaging approaches. Curr Protoc Cell Biol. 2010; Chapter 4:Unit 4.25.1-21. PMC: 3007120. DOI: 10.1002/0471143030.cb0425s46. View